If your Child is Infected with INDIAN Variant, their organs might fail in the future even if they have recovered from the Covid infection

[SBFNews]

India battles surge in cases of rare deadly inflammatory syndrome striking children who caught Covid weeks after they have seemingly recovered​

• India is battling a surge in cases of a deadly inflammatory syndrome, MIS-C
• Over 2,000 cases have been reported across country, with 200 in Delhi alone
• Illness first develops as a high fever and leads to inflammation of the organs

By SOPHIE TANNO FOR MAILONLINE
PUBLISHED: 01:56 BST, 7 June 2021 | UPDATED: 01:58 BST, 7 June 2021

India is battling a surge in cases of a deadly inflammatory syndrome striking children who have caught Covid-19.

The Multisystem Inflammatory Syndrome in Children (MIS-C) affects children who have seemingly recovered from Covid-19, two to six weeks after the infection.

MIS-C largely affects children aged between 5 and 15.

Over 2,000 cases have been reported across the country, with 200 in Delhi alone.
The illness first develops as a high fever and leads to inflammation of the organs.

Around 70 per cent of children affected require intensive care.

India is battling a surge in cases of a deadly inflammatory syndrome striking children who have caught Covid-19. Above, a health worker takes a nasal swab sample of a child to test for COVID-19 during a door to door testing drive in Gauhati, India

Dr Harish Pemde, director of paediatrics at Lady Hardinge Medical College in Delhi, told the Times: 'It can lead to heart, respiratory or renal failure.

'The long-term quality of life of children who recover depends on how badly the organs were affected.

'It's crucial to catch it early when it is fairly easy to treat.'

In April, a study found that half of all children who develop the rare inflammatory condition linked to COVID-19 have neurological symptoms or signs.

Researchers looked at youngsters diagnosed with multisystem inflammatory syndrome in children (MIS-C), a condition in which different body parts become inflamed.

The most common symptom was headache, but children could also develop more serious side effects such as hallucinations or seizures.

The team, from The the American Academy of Neurology, says the findings show why it's important for doctors to carefully monitor pediatric patients with COVID-19 to see if they develop any of these worrying signs.

In a new study, researchers looked at 46 pediatric patients diagnosed with multisystem inflammatory syndrome in children (MIS-C), 24 of whom develop neurological symptoms and signs

MIS-C was originally thought to be linked with Kawasaki disease, a condition that causes inflammation in the walls of the blood vessels and affects mostly children under five years old.

Cases were first reported in Britain, Italy and Spain in April 2020 and began cropping up in the U.S. in May.

Not every child who has developed the condition has tested positive for coronavirus, but 98 percent have - enough for doctors to believe the conditions are linked.

Doctors have revealed the most common locations and types of skin rash found in children with a rare coronavirus-related hyperinflammation condition.

Named MIS-C, patients were first diagnosed in 2020 after doctors noticed some children developed inflammation in a range of organs after exposure to SARS-CoV-2, with the Centre for Disease Control saying it can be fatal, but most children survive.

Experts from the Children's Hospital of Philadelphia say diagnosing MIS-C has proved difficult as many of its symptoms, including rash, fever and gastrointestinal distress, are similar to other childhood conditions.

Small 5p sized plaques appear on the back of a child with MIS-C with tiny red spots inside

The team found that while there was no single location for rashes to appear - they commonly occurred on the lower limbs, inner thigh, chest and upper extremities.
In more than half of the seven patients examined, they usually presented as small to medium circles the size of a 5p coin with tiny red spots in the centre.

Authors hope that by highlighting common coronavirus rashes in children, their findings may help doctors and parents know when a rash needs further study.

 

[sweetiepie]

KNN lai liao lai liao the formula 1 little sinkie head = 1k sinkie old fart heads KNN just imagine we just need to trade 100 little sinkie heads for 100k sinkie fart heads and pap will automaticallee leesappear without any erection KNN

 

[SBFNews]

Your child will probably be uninsurable or super premiums have to be paid in future once insurance companies mandate a mandatory declaration on Covid infection.

 

[glockman]

India is simply a very filthy country. Unhygienic environment, a petri dish for viruses and bacteria.

 

[mojito]

Can not HOTA?

 

[laksaboy]

Perhaps parents attending the funerals of their young children will be a common sight in the near future.

New normal, return to normalcy, Great Reset, sustainable development etc.

 

[batman1]

Pray for retribution to the PAP.

 

[nirvarq]

EMA authorises Pfizer/BioNTech’s COVID-19 vaccine for children aged 12 to 15​

Clinical trial data recently showed that the vaccine is safe and effective in individuals in this age group​

Pfizer and BioNTech’s mRNA-based COVID-19 vaccine has been approved for children aged 12 to 15 in the European Union (EU).
The European Medicines Agency (EMA) has authorised the vaccine for this younger age group after data recently showed that it is safe and effective in individuals aged 12 to 15.
The vaccine, which is authorised in the EU under the brand name Comirnaty, was found in a clinical trial to produce an immune response in this age group that was comparable to the immune response seen in the 16 to 25 year age group.
The most common side effects in children aged 12 to 15 are similar to those observed in people aged 16 and above, the EMA said in a statement.
This includes pain at the injection site, tiredness, headache, muscle and joint pain, chills and fever. These are typically mild or moderate and improve ‘within a few days’.
"From a safety perspective, the vaccine was well tolerated and the side effects in this age group were very much similar to what we have seen in young adults and not raising major concerns at this point in time,” said Marco Cavaleri, head of vaccine strategy at the EMA.
The US Food and Drug Administration (FDA) has already expanded its emergency use authorisation (EUA) for the Pfizer/BioNTech vaccine in 12- to 15-year-olds, and Canada has also approved the jab in this age group.
A spokesman for Pfizer previously confirmed that the company has submitted data for the vaccine in 12- to 15-year-olds to the UK Medicines and Healthcare products Regulatory Agency (MHRA).
NHS England created contingency plans last month for vaccination of children of secondary school age later this year. This proposal is to be included in ‘core planning scenario’ documents showing that a single dose of the jab could be offered to children aged 12 and over at the start of the autumn term.
“It is very important to enable [children] to get back to everyday school life and to meet friends and family while protecting them and their loved ones,” said Ugur Sahin, chief executive officer and co-founder of BioNTech.


http://www.pmlive.com/pharma_news/e...id-19_vaccine_for_children_aged_12-15_1370985

​

 

[syed putra]

I was told, invermectin cures those suffering from long term effect of covid. So no worries.

 

[nirvarq]

I was told, invermectin cures those suffering from long term effect of covid. So no worries.

Probably that's why they remove it ? :

In a sweeping shift in the treatment of covid-19 patients, the Union health ministry has removed usage of popular drugs such as Ivermectin.
08 Jun 2021, 05:57 AM IST

https://www.livemint.com/news/india...-check-revised-guidelines-11623074154396.html

 

[nirvarq]

ANOTHER DOCTOR’S TAKE ON COVID-19 SITUATION

In recent days, a message by another doctor has been circulating on WhatsApp, where he talks about the use of mRNA vaccines, saying that they are ineffective in tackling the B1617 coronavirus variant that was first detected in India.

The message originated from Dr Gabriel Oon Chong Jin, a retired oncologist who is a pioneer in liver cancer research here.

Dr Oon, 82, played a key role in Singapore’s hepatitis B vaccination programme that began in the late 1970s. Hepatitis B is a liver infection caused by a virus.

When contacted by TODAY on Friday, Dr Oon, who last practised at Mount Elizabeth Medical Centre, confirmed that the content of the message was from him.

READ ALSO
Covid-19 vaccination: MOH to provide financial assistance for people affected by serious side effects
In the message, he wrote that mutations in the spike protein of the coronavirus causing Covid-19 has altered its antigenicity — or its ability to bind to cell walls.

The spike protein is the part of the virus that it uses to penetrate human cells so that it can bind with the cells more effectively and cause infection.

When the antigenicity changes, vaccines that use the new mRNA technology such as Pfizer-BioNTech cannot recognise the mutant variant such as the B1617 one.

Only a vaccine such as Sinovac that has an inactivated virus “with all its seven antigens” can still produce an immune response even when one antigen of the active invading virus is affected by mutation, Dr Oon wrote.

He added that the B1617 variant had successfully infected vaccinated frontliners and airport staff members, as well as school children in Singapore.

“Pfizer is useless now and obsolete in the presence of mutations on (the) spike gene,” the message read.

READ ALSO
WHO approves Sinovac Covid-19 vaccine for emergency use
He also said in the message that “China vaccines” can overcome the B1617 variant and that he had written in to the authorities to consider using Sinovac.

The Sinovac vaccine may be suitable for children, and even babies, but at a lowered dosage, he added.

When asked by TODAY to comment more about his concerns, Dr Oon stressed again that mRNA vaccines are “useless” against the B1617 mutant and that the variant should be seen as a “new infection”.

“I would say it is a time of emergency, a time to change and use another vaccine such as Sinovac, which we already have in stock,” he said, referring to the shipment of the vaccine Singapore received in February and pending approval for use here.

Dr Oon continued: “If we keep vaccinating people with mRNA vaccines like Pfizer, we are endangering the lives of so many people around us who will still get infected, not to mention the person who is vaccinated."

It is a doctor's duty to call immediately for a change of treatment if it is not working for a patient who has a life-threatening condition, he said by way of example.

Dr Oon’s circulated message on WhatsApp mentioned that he had reached out to various Cabinet ministers, including Health Minister Ong Ye Kung, on the mRNA vaccines and Sinovac.

Dr Oon confirmed that he had done this, at around the time news broke of the B1617 variant.

He declined to give more details on the recommendations he proposed to the Government as mentioned in the message.

TODAY understands that MOH is aware of Dr Oon’s circulated message since last month and had addressed some of his concerns in the same statement last month issued regarding the open letter by the doctors to parents.

That statement did not address Dr Oon’s concerns on how effective mRNA vaccines are on mutated variants.
Read more at https://www.todayonline.com/singapo...ne-fees-selected-vaccine-takers-be-reimbursed

 

[rushifa666]

Ns and vaccine will kill him forst. The moderna boy is a lottery winner